Stratasys Q3 2026: Defense Demand Snaps a Two-Quarter Loss Streak

Stratasys reported adjusted non-GAAP earnings of $0.04 per share for the third quarter of 2026, beating the consensus estimate of roughly $0.02 by nearly 78%. Revenue came in at $142.64 million, just ahead of the $141.92 million estimate and up 4.1% from the same quarter a year earlier. The return to profitability ended two consecutive quarters of adjusted losses, in Q1 and Q2 2026, and gave investors something concrete to work with after a prolonged stretch of mixed results.

The clearest engine behind the quarter was aerospace and defense, which grew more than 35% year over year and roughly 25% sequentially. CEO Yoav Zeif pointed to two significant defense orders and strong follow-on demand for embedded, flight-grade production programs spanning drones, space, munitions, and advanced air mobility. That segment's acceleration also pulled the product mix toward higher-margin systems, helping non-GAAP gross margin widen to 47.8% from 45.3% a year earlier. Adjusted EBITDA climbed to $8 million from $5 million in the prior-year quarter.

The quarter also showed progress outside defense. Systems revenue rose about 12% year over year to $35.9 million, automotive and dental both contributed growth, and Stratasys Direct expanded 9%, itself driven by aerospace and defense work. GAAP operating expenses fell to $73.3 million from $78.8 million, partly because there was no impairment charge to absorb this quarter, compared with a $33.9 million Ultimaker impairment in the year-ago period.

Management did cut the full-year 2026 revenue outlook, trimming the range to $556 million to $561 million from a prior range of $565 million to $575 million. The reason cited was longer and more variable sales cycles for large, production-focused orders rather than weaker demand. Zeif described customer engagement across the pipeline as robust but acknowledged the timing on big awards is harder to predict. The company maintained its expectation for positive operating cash flow in the second half of 2026, and the balance sheet carries no debt.

Investors watching the stock should focus on whether the defense momentum can sustain the gross-margin improvement into the fourth quarter, and whether those slower-closing production orders actually land within the revised guidance window. The consumables line, which slipped 1.3% year over year, is a quieter concern: consumables are a recurring-revenue indicator, and a prolonged softness there would complicate the story of a durable shift from prototyping to production manufacturing that management is building.